resistance to antibiotics
Recently Published Documents


TOTAL DOCUMENTS

559
(FIVE YEARS 119)

H-INDEX

52
(FIVE YEARS 4)

mBio ◽  
2021 ◽  
Vol 12 (6) ◽  
Author(s):  
Yong Lai ◽  
Liang Cui ◽  
Gregory H. Babunovic ◽  
Sarah M. Fortune ◽  
John G. Doench ◽  
...  

Treatment for shigellosis is becoming increasingly difficult as resistance to antibiotics becomes more prevalent. One way to prevent this significant public health problem from developing into a full-blown crisis is to approach shigellosis intervention from the point of view of the host.


2021 ◽  
Vol 31 (7) ◽  
pp. 120-124
Author(s):  
Žaneta Maželienė ◽  
Asta Aleksandravičienė ◽  
Aušrinė Petrauskaitė ◽  
Ingrida Viliušienė ◽  
Daiva Šakienė

Staphylococci are human and animal mucosal surface and skin commensals that can cause a variety of infections, such as purulent skin infections, otitis externa, pyoderma, urinary tract infections, and postoperative infections. Dog skin is one of the protective barriers for animals. However, dogs can have and transmit a variety of microorganisms on their skin, including staphylococci. Most studies have compared plasma coagulating and non-coagulating Staphylococcus spp. by dog breeds, sex, and coat length. The aim – to identify plasma coagulating and non-coagulating Staphylococcus spp. in skin samples from dogs and its resistance to antibiotics by place of residence. Staphylococci were detected in more than half of the samples tested, one third of which were plasma coagulating and the remaining two thirds were non-coagulating plasma. Plasma non-coagulating staphylococci were mainly increased among dogs living at home and plasma coagulating – among dogs living outdoors, the difference between these groups is statistically significant. Staphylococcus aureus was predominantly resistant to penicillin and clindamycin, while plasma non-coagulants were resistant to fusidic acid.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Yuye Wu ◽  
Dheerendranath Battalapalli ◽  
Mohammed J. Hakeem ◽  
Venkatarao Selamneni ◽  
Pengfei Zhang ◽  
...  

AbstractAntibiotic resistance is spreading rapidly around the world and seriously impeding efforts to control microbial infections. Although nucleic acid testing is widely deployed for the detection of antibiotic resistant bacteria, the current techniques—mainly based on polymerase chain reaction (PCR)—are time-consuming and laborious. There is an urgent need to develop new strategies to control bacterial infections and the spread of antimicrobial resistance (AMR). The CRISPR-Cas system is an adaptive immune system found in many prokaryotes that presents attractive opportunities to target and edit nucleic acids with high precision and reliability. Engineered CRISPR-Cas systems are reported to effectively kill bacteria or even revert bacterial resistance to antibiotics (resensitizing bacterial cells to antibiotics). Strategies for combating antimicrobial resistance using CRISPR (i.e., Cas9, Cas12, Cas13, and Cas14) can be of great significance in detecting bacteria and their resistance to antibiotics. This review discusses the structures, mechanisms, and detection methods of CRISPR-Cas systems and how these systems can be engineered for the rapid and reliable detection of bacteria using various approaches, with a particular focus on nanoparticles. In addition, we summarize the most recent advances in applying the CRISPR-Cas system for virulence modulation of bacterial infections and combating antimicrobial resistance. Graphical Abstract


PLoS ONE ◽  
2021 ◽  
Vol 16 (11) ◽  
pp. e0260677
Author(s):  
Laura Willerton ◽  
Jay Lucidarme ◽  
Andrew Walker ◽  
Aiswarya Lekshmi ◽  
Stephen A. Clark ◽  
...  

Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, can have a fatality rate as high as 10%, even with appropriate treatment. In the UK, penicillin is administered to patients in primary care whilst third generation cephalosporins, cefotaxime and ceftriaxone, are administered in secondary care. The first-choice antibiotic for chemoprophylaxis of close contacts is ciprofloxacin, followed by rifampicin. Immunocompromised individuals are often recommended antibiotic chemoprophylaxis and vaccination due to a greater risk of IMD. Resistance to antibiotics among meningococci is relatively rare, however reduced susceptibility and resistance to penicillin are increasing globally. Resistance to third generation cephalosporins is seldom reported, however reduced susceptibility to both cefotaxime and ceftriaxone has been observed. Rifampicin resistance has been reported among meningococci, mainly following prophylaxis, and ciprofloxacin resistance, whilst uncommon, has also been reported across the globe. The Public Health England Meningococcal Reference Unit receives and characterises the majority of isolates from IMD cases in England, Wales and Northern Ireland. This study assessed the distribution of antibiotic resistance to penicillin, rifampicin, ciprofloxacin and cefotaxime among IMD isolates received at the MRU from 2010/11 to 2018/19 (n = 4,122). Out of the 4,122 IMD isolates, 113 were penicillin-resistant, five were ciprofloxacin-resistant, two were rifampicin-resistant, and one was cefotaxime-resistant. Penicillin resistance was due to altered penA alleles whilst rifampicin and ciprofloxacin resistance was due to altered rpoB and gyrA alleles, respectively. Cefotaxime resistance was observed in one isolate which had an altered penA allele containing additional mutations to those harboured by the penicillin-resistant isolates. This study identified several isolates with resistance to antibiotics used for current treatment and prophylaxis of IMD and highlights the need for continued surveillance of resistance among meningococci to ensure continued effective use.


2021 ◽  
Vol 67 (3) ◽  
pp. 24-34
Author(s):  
Payman Ali Kareem ◽  
Khonaw Kader Salh ◽  
Fattma A. Ali

The economic approaches for manufacturing the nanoparticles with physical and chemical effects and limited resistance to antibiotics have been progressed recently due to the rise of microbial resistance to antibiotics. This research aimed to study the antimicrobial efficacy of silver nanoparticles Ag, ZnO, and Tio2 nanoparticles against Salmonella typhimurium and Brucella abortus and Candida albicans. Two isolates of Salmonella and two isolates of Brucella abortus were isolated from food spastically meat and blood specimens, respectively. Candida albicans were isolated from the patient's mouth with oral candidiasis (oral thrush) and confirmed diagnosis by API 20C test. The antimicrobial susceptibility of Salmonella typhimurium and B. abortus isolates were performed against nine different antibiotics. Silver nanoparticles consisting of AgNPs size (90) nm, ZnO NPs size (20, 50) nm as well as TiO2 NPs size (10, 50) nm, were used. UV-Visible spectrophotometer was used to characterize silver nanoparticles. The highest resistance of Candida albicans was seen for fluconazole, Clotrimazole and Itraconazole. The results of the Minimum Inhibitory Concentration (MIC) of nanoparticles against Salmonella typhimurium showed the average MIC of Tio2-10nm and Tio2-50nm were 5000 and 2500 ?g\ml for S1 and S2 isolates, respectively. The isolated Brucella abortus (B1 and B2) showed sensitivity to NPs with different MIC. The average MIC for Ag-90nm was 5000 and 2500 µg/ml for B1 and B2 isolates, respectively. The findings suggest Ag solution has fungicidal and bactericidal impacts on the tested microorganisms so they can be suitable for multiple applications of the biomedical field such as developing new antimicrobial agents.


2021 ◽  
Vol 8 ◽  
Author(s):  
Ema Aleksić ◽  
Biljana Miljković-Selimović ◽  
Zoran Tambur ◽  
Nikola Aleksić ◽  
Vladimir Biočanin ◽  
...  

Campylobacter jejuni (C. jejuni) is one of the most frequent causes of bacterial enterocolitis globally. The disease in human is usually self-limiting, but when complications arise antibiotic therapy is required at a time when resistance to antibiotics is increasing worldwide. Mechanisms of antibiotic resistance in bacteria are diverse depending on antibiotic type and usage and include: enzymatic destruction or drug inactivation; alteration of the target enzyme; alteration of cell membrane permeability; alteration of ribosome structure and alteration of the metabolic pathway(s). Resistance of Campylobacter spp. to antibiotics, especially fluoroquinolones is now a major public health problem in developed and developing countries. In this review the mechanisms of resistance to fluoroquinolones, macrolides, tetracycline, aminoglycoside and the role of integrons in resistance of Campylobacter (especially at the molecular level) are discussed, as well as the mechanisms of resistance to β-lactam antibiotics, sulphonamides and trimethoprim. Multiple drug resistance is an increasing problem for treatment of campylobacter infections and emergence of resistant strains and resistance are important One Health issues.


2021 ◽  
Vol 11 (5-S) ◽  
pp. 33-41
Author(s):  
Nadlaou Bessimbaye ◽  
Ali Mahamat Moussa ◽  
Mayanna Habkréo ◽  
Ali Senoussi Moukhtar ◽  
Choua Ouchemi

Helicobacter pylori infection and resistance to antibiotics is a public health problem. The objective of this study was to determine the prevalence and rates of resistance to antibiotics used in the protocol for the management of patients with Helicobacter pylori infection. Spanning a period from February 2020 to February 2021, it was an observational diagnostic study on gastric biopsies and stool including 97 patients admitted for endoscopy. It was carried out according to standard methods of medical microbiology. Of 97 patients whose mean age was 46.10 years with extremes of 16 and 85 years, an infection prevalence of 60.82% was observed. 44.07% of infected patients were between 16 and 39 years old, 33.90% between 40 and 63 years old, and 22.03% between 63 and 85 years old. Significant differences were observed between the proportions of positive (81.44%) and negative (18.56%) cultures, between infection with H. pylori (75%) and other microbial agents (25.35%) with probabilities of 0.01 and 0.02 respectively. The most resistant antibiotics were: Metronidazole, Clarithromycin, Levofloxacin, Tetracycline and Amoxicillin with resistance rates of 74.58%, 16.95%, 13.56%, 8.47%, and 5.08% respectively.  The frequencies of antibiotic resistance revealed 74.58% for Metronidazole, 16.95% for Clarithromycin, 13.56% for Levofloxacin, 8.47% for Tetracycline, and 5.08% for Amoxicillin. This study made it possible to determine a significant proportion of H. pylori infection and to shed light on the resistance to the antibiotics used in the eradicating treatment of the bacteria. From this study, we retain that the prescription of Metronidazole is prohibited in Chad. Keywords: Helicobacter pylori, Resistance, Antibiotic, Chad.


Author(s):  
Jessica Rubí Morán Díaz ◽  
Juan Alberto Guevara-Salazar ◽  
Roberto Issac Cuevas Hernández ◽  
José Guadalupe Trujillo Ferrara

Sign in / Sign up

Export Citation Format

Share Document